Haleon (LON:HLN) Sets New 52-Week Low - Should You Sell?

Key Points

• Haleon plc's stock reached a new 52-week low of GBX 335.10 ($4.56) on Tuesday, with analysts issuing mixed ratings on the stock, leading to a consensus rating of "Hold" and a target price of GBX 436.67.
• The company's recent earnings report showed a net margin of 9.66% and an earnings per share (EPS) of GBX 8.90, with analysts predicting an EPS of approximately 19.50 for the current year.
• Insider selling activity was noted, with Dawn Allen selling 64,329 shares at an average price of GBX 376, raising concerns over investor confidence as insiders own only 0.01% of the stock.

Haleon plc (LON:HLN - Get Free Report)'s stock price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 335.10 ($4.56) and last traded at GBX 346.90 ($4.72), with a volume of 119930961 shares trading hands. The stock had previously closed at GBX 356.70 ($4.85).

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on HLN shares. The Goldman Sachs Group reiterated a "buy" rating and set a GBX 440 target price on shares of Haleon in a research note on Wednesday, September 10th. Royal Bank Of Canada reissued a "sector perform" rating and set a GBX 370 price target on shares of Haleon in a research report on Thursday, July 31st. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of Haleon in a report on Friday, August 1st. Finally, Berenberg Bank reduced their target price on Haleon from GBX 503 to GBX 500 and set a "buy" rating on the stock in a report on Friday, August 8th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of GBX 436.67.

Haleon Trading Down 3.3%

The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36. The firm has a 50 day moving average of GBX 361.53 and a 200 day moving average of GBX 380.53. The firm has a market cap of £30.89 billion, a PE ratio of 2,066.47, a P/E/G ratio of 1.49 and a beta of 0.19.

Haleon (LON:HLN - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported GBX 8.90 earnings per share (EPS) for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. Equities analysts anticipate that Haleon plc will post 19.5033282 earnings per share for the current year.

Insider Activity

In other news, insider Dawn Allen sold 64,329 shares of the company's stock in a transaction on Monday, June 30th. The stock was sold at an average price of GBX 376, for a total value of £241,877.04. 0.01% of the stock is currently owned by insiders.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.